Lv6
2736 积分 2022-11-30 加入
Discovery of an Oral, Rule of 5 Compliant, Interleukin 17A Protein–Protein Interaction Modulator for the Potential Treatment of Psoriasis and Other Inflammatory Diseases
6天前
已完结
Efficacy and safety of vunakizumab in moderate-to-severe chronic plaque psoriasis: A randomized, double-blind, placebo-controlled phase 3 trial
7天前
已完结
A multicentre randomized double-blind placebo-controlled phase III study of the efficacy and safety of xeligekimab (GR1501) in patients with moderate-to-severe plaque psoriasis
7天前
已完结
Small-molecule drug discovery targeting the orphan G protein-coupled receptor GPR84 as potential therapeutics
14天前
已完结
Tomivosertib reduces ectopic activity in dorsal root ganglion neurons from patients with radiculopathy
20天前
已完结
Activation of Neuronal Voltage-Gated Potassium Kv7/KCNQ/M-Current by a Novel Channel Opener SCR2682 for Alleviation of Chronic Pain
21天前
已完结
Update on the Development of MNK Inhibitors as Therapeutic Agents
21天前
已完结
MNK1 and MNK2 Expression in the Human Dorsal Root and Trigeminal Ganglion
22天前
已完结
Pharmacodynamic evaluation of AUM001/tinodasertib, an oral inhibitor of mitogen-activated protein kinase (MAPK)-interacting protein kinase 1, 2 (MNK1/2) in preclinical models and tissues from a Phase 1 clinical study
22天前
已完结
皖公网安备34019202002308
